"currently standing"

#12052306

14 February 2025

Iranian men puff on horns while standing on a rooftop of a holy shrine during a religious festival to welcome Imam Mahdi's Birthday anniversary in northern Tehran, Iran, on February 13, 2025. Twelver Shia Muslims believe Muhammad ibn Hasan al-Mahdi is the twelfth and final Imam, currently in occultation. He is the awaited Mahdi who will return at the end of time to establish peace, justice, and the righteous rule of Islam.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12052307

14 February 2025

Iranian men puff on horns while standing on a rooftop of a holy shrine during a religious festival to welcome Imam Mahdi's Birthday anniversary in northern Tehran, Iran, on February 13, 2025. Twelver Shia Muslims believe Muhammad ibn Hasan al-Mahdi is the twelfth and final Imam, currently in occultation. He is the awaited Mahdi who will return at the end of time to establish peace, justice, and the righteous rule of Islam.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12052309

14 February 2025

Iranian women wearing veils look up while standing at a holy shrine during a religious festival to welcome Imam Mahdi's Birthday anniversary in northern Tehran, Iran, on February 13, 2025. Twelver Shia Muslims believe Muhammad ibn Hasan al-Mahdi is the twelfth and final Imam, currently in occultation. He is the awaited Mahdi who will return at the end of time to establish peace, justice, and the righteous rule of Islam.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950561

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950562

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950563

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950564

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950565

16 January 2025

A desk filled with documents during the testing of the new AILIS machine as part of clinical trials aimed at detecting breast cancer, in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. Using Parametric Dynamic Imaging (PDI) and artificial intelligence, it can distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials are currently conducted in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950566

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950567

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950572

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950573

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950574

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950581

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950585

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950589

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.